Los Angeles Capital Management LLC Albireo Pharma, Inc. Transaction History

Los Angeles Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$18.54 - $37.29 $381,052 - $766,421	-20,553 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$23.94 - $33.74 $193,195 - $272,281	-8,070 Reduced 28.19%	20,553 $613,000
Q4 2021 Feb 03, 2022	SELL	$21.19 - $31.29 $3,538 - $5,225	-167 Reduced 0.58%	28,623 $667,000
Q3 2021 Nov 08, 2021	SELL	$27.36 - $35.98 $9,165 - $12,053	-335 Reduced 1.15%	28,790 $898,000
Q2 2021 Aug 05, 2021	BUY	$28.9 - $36.87 $31,501 - $40,188	1,090 Added 3.89%	29,125 $1.03 Million
Q1 2021 May 05, 2021	SELL	$32.03 - $42.85 $356,493 - $476,920	-11,130 Reduced 28.42%	28,035 $988,000
Q4 2020 Feb 04, 2021	BUY	$31.56 - $42.16 $576,759 - $770,473	18,275 Added 87.48%	39,165 $1.47 Million
Q3 2020 Nov 02, 2020	BUY	$23.19 - $41.61 $180,418 - $323,725	7,780 Added 59.34%	20,890 $697,000
Q2 2020 Aug 05, 2020	BUY	$14.82 - $29.92 $194,290 - $392,251	13,110 New	13,110 $347,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.